Cargando…

Long-Term Cryostorage of Mesenchymal Stem Cell-Containing Hybrid Hydrogel Scaffolds Based on Fibrin and Collagen

The most difficult issue when using tissue engineering products is enabling the ability to store them without losing their restorative capacity. The numbers and viability of mesenchymal stem cells encapsulated in a hydrogel scaffold after cryostorage at −80 °C (by using, individually, two kinds of c...

Descripción completa

Detalles Bibliográficos
Autores principales: Egorikhina, Marfa N., Rubtsova, Yulia P., Aleynik, Diana Ya.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7709639/
https://www.ncbi.nlm.nih.gov/pubmed/33255558
http://dx.doi.org/10.3390/gels6040044
_version_ 1783617793315307520
author Egorikhina, Marfa N.
Rubtsova, Yulia P.
Aleynik, Diana Ya.
author_facet Egorikhina, Marfa N.
Rubtsova, Yulia P.
Aleynik, Diana Ya.
author_sort Egorikhina, Marfa N.
collection PubMed
description The most difficult issue when using tissue engineering products is enabling the ability to store them without losing their restorative capacity. The numbers and viability of mesenchymal stem cells encapsulated in a hydrogel scaffold after cryostorage at −80 °C (by using, individually, two kinds of cryoprotectors—Bambanker and 10% DMSO (Dimethyl sulfoxide) solution) for 3, 6, 9, and 12 months were determined, with subsequent assessment of cell proliferation after 96 h. The analysis of the cellular component was performed using fluorescence microscopy and the two fluorochromes—Hoechst 3334 and NucGreenTM Dead 488. The experimental protocol ensured the preservation of cells in the scaffold structure, retaining both high viability and proliferative activity during storage for 3 months. Longer storage of scaffolds led to their significant changes. Therefore, after 6 months, the proliferative activity of cells decreased. Cryostorage of scaffolds for 9 months led to a decrease in cells’ viability and proliferative activity. As a result of cryostorage of scaffolds for 12 months, a decrease in viability and proliferative activity of cells was observed, as well as pronounced changes in the structure of the hydrogel. The described scaffold cryostorage protocol could become the basis for the development of storage protocols for such tissue engineering products, and for helping to extend the possibilities of their clinical use while accelerating their commercialization.
format Online
Article
Text
id pubmed-7709639
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-77096392020-12-03 Long-Term Cryostorage of Mesenchymal Stem Cell-Containing Hybrid Hydrogel Scaffolds Based on Fibrin and Collagen Egorikhina, Marfa N. Rubtsova, Yulia P. Aleynik, Diana Ya. Gels Article The most difficult issue when using tissue engineering products is enabling the ability to store them without losing their restorative capacity. The numbers and viability of mesenchymal stem cells encapsulated in a hydrogel scaffold after cryostorage at −80 °C (by using, individually, two kinds of cryoprotectors—Bambanker and 10% DMSO (Dimethyl sulfoxide) solution) for 3, 6, 9, and 12 months were determined, with subsequent assessment of cell proliferation after 96 h. The analysis of the cellular component was performed using fluorescence microscopy and the two fluorochromes—Hoechst 3334 and NucGreenTM Dead 488. The experimental protocol ensured the preservation of cells in the scaffold structure, retaining both high viability and proliferative activity during storage for 3 months. Longer storage of scaffolds led to their significant changes. Therefore, after 6 months, the proliferative activity of cells decreased. Cryostorage of scaffolds for 9 months led to a decrease in cells’ viability and proliferative activity. As a result of cryostorage of scaffolds for 12 months, a decrease in viability and proliferative activity of cells was observed, as well as pronounced changes in the structure of the hydrogel. The described scaffold cryostorage protocol could become the basis for the development of storage protocols for such tissue engineering products, and for helping to extend the possibilities of their clinical use while accelerating their commercialization. MDPI 2020-11-25 /pmc/articles/PMC7709639/ /pubmed/33255558 http://dx.doi.org/10.3390/gels6040044 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Egorikhina, Marfa N.
Rubtsova, Yulia P.
Aleynik, Diana Ya.
Long-Term Cryostorage of Mesenchymal Stem Cell-Containing Hybrid Hydrogel Scaffolds Based on Fibrin and Collagen
title Long-Term Cryostorage of Mesenchymal Stem Cell-Containing Hybrid Hydrogel Scaffolds Based on Fibrin and Collagen
title_full Long-Term Cryostorage of Mesenchymal Stem Cell-Containing Hybrid Hydrogel Scaffolds Based on Fibrin and Collagen
title_fullStr Long-Term Cryostorage of Mesenchymal Stem Cell-Containing Hybrid Hydrogel Scaffolds Based on Fibrin and Collagen
title_full_unstemmed Long-Term Cryostorage of Mesenchymal Stem Cell-Containing Hybrid Hydrogel Scaffolds Based on Fibrin and Collagen
title_short Long-Term Cryostorage of Mesenchymal Stem Cell-Containing Hybrid Hydrogel Scaffolds Based on Fibrin and Collagen
title_sort long-term cryostorage of mesenchymal stem cell-containing hybrid hydrogel scaffolds based on fibrin and collagen
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7709639/
https://www.ncbi.nlm.nih.gov/pubmed/33255558
http://dx.doi.org/10.3390/gels6040044
work_keys_str_mv AT egorikhinamarfan longtermcryostorageofmesenchymalstemcellcontaininghybridhydrogelscaffoldsbasedonfibrinandcollagen
AT rubtsovayuliap longtermcryostorageofmesenchymalstemcellcontaininghybridhydrogelscaffoldsbasedonfibrinandcollagen
AT aleynikdianaya longtermcryostorageofmesenchymalstemcellcontaininghybridhydrogelscaffoldsbasedonfibrinandcollagen